Shweta , Sharma K, Shakarad M, Agrawal N, Maurya S
Mol Biol Rep. 2024; 51(1):1146.
PMID: 39532789
DOI: 10.1007/s11033-024-10075-w.
Akbari-Gharalari N, Ghahremani-Nasab M, Naderi R, Chodari L, Nezhadshahmohammad F
AIMS Neurosci. 2024; 11(3):374-397.
PMID: 39431275
PMC: 11486621.
DOI: 10.3934/Neuroscience.2024023.
Basso V, Dobrossy M, Thompson L, Kirik D, Fuller H, Gates M
Biology (Basel). 2024; 13(9).
PMID: 39336117
PMC: 11428604.
DOI: 10.3390/biology13090690.
Demailly A, Moreau C, Devos D
J Parkinsons Dis. 2024; 14(5):925-939.
PMID: 38848195
PMC: 11307025.
DOI: 10.3233/JPD-230372.
Dues D, Ma Y, Nguyen A, Offerman A, Beddows I, Moore D
Neurobiol Dis. 2024; 188.
PMID: 38435455
PMC: 10906965.
DOI: 10.1016/j.nbd.2023.106338.
Axonal Lysosomal Assays for Characterizing the Effects of LRRK2 G2019S.
Bhatia P, Bickle M, Agrawal A, Truss B, Nikolaidi A, Brockmann K
Biology (Basel). 2024; 13(1).
PMID: 38275734
PMC: 10813644.
DOI: 10.3390/biology13010058.
The role of exosomes in the diagnosis of Parkinson's disease.
Shi Q, Kang W, Liu Z, Zhu X
Heliyon. 2023; 9(10):e20595.
PMID: 37928387
PMC: 10622621.
DOI: 10.1016/j.heliyon.2023.e20595.
Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson's disease.
Sastre D, Zafar F, Torres C, Piper D, Kirik D, Sanders L
Sci Rep. 2023; 13(1):17796.
PMID: 37853101
PMC: 10584834.
DOI: 10.1038/s41598-023-45078-3.
A sporadic Parkinson's disease model via silencing of the ubiquitin-proteasome/E3 ligase component, SKP1A.
Fishman-Jacob T, Youdim M
J Neural Transm (Vienna). 2023; 131(6):675-707.
PMID: 37644186
PMC: 11192832.
DOI: 10.1007/s00702-023-02687-6.
Hippocampal subfield vulnerability to α-synuclein pathology precedes neurodegeneration and cognitive dysfunction.
Dues D, Nguyen A, Becker K, Ma J, Moore D
NPJ Parkinsons Dis. 2023; 9(1):125.
PMID: 37640722
PMC: 10462636.
DOI: 10.1038/s41531-023-00574-1.
Neuronavigated repetitive transcranial magnetic stimulation improves depression, anxiety and motor symptoms in Parkinson's disease.
Jiang S, Zhan C, He P, Feng S, Gao Y, Zhao J
Heliyon. 2023; 9(8):e18364.
PMID: 37533995
PMC: 10392019.
DOI: 10.1016/j.heliyon.2023.e18364.
Future Directions for Developing Non-dopaminergic Strategies for the Treatment of Parkinson's Disease.
van Wamelen D, Leta V, Chaudhuri K, Jenner P
Curr Neuropharmacol. 2023; 22(10):1606-1620.
PMID: 37526188
PMC: 11284721.
DOI: 10.2174/1570159X21666230731110709.
Prediction of Cognitive Decline in Parkinson's Disease Using Clinical and DAT SPECT Imaging Features, and Hybrid Machine Learning Systems.
Hosseinzadeh M, Gorji A, Fathi Jouzdani A, Rezaeijo S, Rahmim A, Salmanpour M
Diagnostics (Basel). 2023; 13(10).
PMID: 37238175
PMC: 10217464.
DOI: 10.3390/diagnostics13101691.
Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variant.
Kozhushko N, Beilina A, Cookson M
Stem Cell Res. 2023; 69:103125.
PMID: 37229975
PMC: 10411637.
DOI: 10.1016/j.scr.2023.103125.
Clinical Evaluation of Sleep Disorders in Parkinson's Disease.
Lauretani F, Testa C, Salvi M, Zucchini I, Giallauria F, Maggio M
Brain Sci. 2023; 13(4).
PMID: 37190574
PMC: 10136671.
DOI: 10.3390/brainsci13040609.
The noradrenergic subtype of Parkinson disease: from animal models to clinical practice.
Chaudhuri K, Leta V, Bannister K, Brooks D, Svenningsson P
Nat Rev Neurol. 2023; 19(6):333-345.
PMID: 37142796
DOI: 10.1038/s41582-023-00802-5.
Hippocampal subfield vulnerability to α-synuclein pathology precedes neurodegeneration and cognitive dysfunction.
Dues D, Nguyen A, Becker K, Ma J, Moore D
bioRxiv. 2023; .
PMID: 37090590
PMC: 10120695.
DOI: 10.1101/2023.04.12.536572.
Dysfunction of the noradrenergic system drives inflammation, α-synucleinopathy, and neuronal loss in mouse colon.
Song S, Tu D, Meng C, Liu J, Wilson B, Wang Q
Front Immunol. 2023; 14:1083513.
PMID: 36845109
PMC: 9950510.
DOI: 10.3389/fimmu.2023.1083513.
Nuclease-dead S. Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in patient-derived stem cell model of Parkinson's disease.
Sastre D, Zafar F, Torres C, Piper D, Kirik D, Sanders L
bioRxiv. 2023; .
PMID: 36747875
PMC: 9900844.
DOI: 10.1101/2023.01.24.525105.
Aggregated alpha-synuclein transcriptionally activates pro-inflammatory canonical and non-canonical NF-κB signaling pathways in peripheral monocytic cells.
Bearoff F, Dhavale D, Kotzbauer P, Kortagere S
Mol Immunol. 2022; 154:1-10.
PMID: 36571978
PMC: 9905308.
DOI: 10.1016/j.molimm.2022.12.006.
